 SOUTH SAN FRANCISCO, Calif., Feb. 17, 2021 GLOBE NEWSWIRE -- Harpoon Therapeutics, Inc. NASDAQ: HARP, a clinical-stage immunotherapy company developing a novel class of T cell engagers, today announced that Gerald McMahon, Ph.D., President and Chief Executive Officer, will participate in a fireside chat at the SVB Leerink 10th Annual Global Healthcare Conference. The discussion will take place on Wednesday, February 24, 2021 at 4:20 p.m. ET 1:20 p.m. PT. 